Agenus
AGEN
$6.15
Share price
-8.48%
Change (1 day)
-15.75%
Change (1 year)
Categories
P/S ratio for Agenus (AGEN)
P/S ratio as of July 2025 (TTM): 1.71
According to Agenus 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.5272. At the end of 2025 the company had a P/S ratio of 0.4069.
P/S ratio history for Agenus from 2001 to 2025
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 0.4069 | -35.17% |
| 2024 | 0.6276 | -68.94% |
| 2023 | 2.02 | -72.93% |
| 2022 | 7.46 | 166.81% |
| 2021 | 2.80 | -60.45% |
| 2020 | 7.07 | 89.19% |
| 2019 | 3.74 | -51.85% |
| 2018 | 7.76 | 1.93% |
| 2017 | 7.62 | -52.1% |
| 2016 | 15.9 | 0.62% |
| 2015 | 15.8 | -55.71% |
| 2014 | 35.7 | 13.25% |
| 2013 | 31.5 | 398.62% |
| 2012 | 6.32 | -59.41% |
| 2011 | 15.6 | -53.6% |
| 2010 | 33.6 | 94.8% |
| 2009 | 17.2 | 43.57% |
| 2008 | 12.0 | -31.32% |
| 2007 | 17.5 | -85.59% |
| 2006 | 121 | -64.81% |
| 2005 | 344 | -47.14% |
| 2004 | 652 | 413.01% |
| 2003 | 127 | 27.82% |
| 2002 | 99.4 | -4.86% |
| 2001 | 104 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Merck MRK | 3.15 | 84.62% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 1.89 | 10.43% | 🇬🇧 UK |
 Johnson & Johnson JNJ | 4.42 | 158.94% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | 202 | 11,702.32% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2.03 | 18.62% | 🇺🇸 USA |